Germany Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 5

2 Introduction 7

• 2.1 What Is This Report About? 7
• 2.2 Diabetes Care Devices Market Segmentation 7
• 2.3 Definitions of Markets Covered in the Report 8

3 Diabetes Care Devices Market, Germany 10

• 3.1 Diabetes Care Devices Market, Germany, Revenue ($m), 2015-2025 10
• 3.2 Diabetes Care Devices Market, Germany, Revenue Mix ($m), 2019 12
• 3.3 Diabetes Care Devices Market, Germany, Category Contribution by Revenue ($m), 2019 13
• 3.4 Diabetes Care Devices Market, Germany, Revenue ($m), 2015-2025 14
• 3.5 Diabetes Care Devices Market, Germany, Volume (Units), 2015-2025 16
• 3.6 Diabetes Care Devices Market, Germany, Volume (Units), 2015-2025 18
• 3.7 Diabetes Care Devices Market, Germany, Company Share by Revenue ($m), 2019 20

4 Glucose Monitoring Market, Germany 22

• 4.1 Glucose Monitoring Market, Germany, Revenue ($m), 2015-2025 22
  • 4.1.1 Blood Glucose Meters Market, Germany, Revenue ($m), by Segment, 2015-2025 24
• 4.2 Glucose Monitoring Market, Germany, Volume (Units), 2015-2025 26
  • 4.2.1 Blood Glucose Meters Market, Germany, Volume (Units), by Segment, 2015-2025 28
• 4.3 Glucose Monitoring Market, Germany, Average Price ($) , 2015-2025 30
• 4.4 Glucose Monitoring Market, Germany, Distribution Share by Revenue ($m), 2019 31
• 4.5 Glucose Monitoring Market, Germany, Company Share by Revenue ($m), 2019 32

5 Insulin Delivery Market, Germany 33

• 5.1 Insulin Delivery Market, Germany, Revenue Mix ($m), 2019 33
• 5.2 Insulin Delivery Market, Germany, Segment Contribution (%), 2019 34
• 5.3 Insulin Delivery Market, Germany, Revenue ($m), 2015-2025 35
  • 5.3.1 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2015-2025 37
  • 5.3.2 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2015-2025 39
• 5.4 Insulin Delivery Market, Germany, Volume (Units), 2015-2025 41
  • 5.4.1 Insulin Pens Market, Germany, Volume (Units), by Segment, 2015-2025 43
  • 5.4.2 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2015-2025 45
• 5.5 Insulin Delivery Market, Germany, Average Price ($), 2015-2025 47
• 5.6 Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), 2019 48
• 5.7 Insulin Delivery Market, Germany, Company Share by Revenue ($m), 2019 49

6 Overview of Key Companies in Germany, Diabetes Care Devices Market 51

• 6.1 Medtronic Plc 51
  • 6.1.1 Company Overview 51
• 6.2 DexCom Inc 51
  • 6.2.1 Company Overview 51
• 6.3 Abbott Laboratories 51
  • 6.3.1 Company Overview 51
• 6.4 Novo Nordisk AS 52
  • 6.4.1 Company Overview 52
• 6.5 Sanofi 52
  • 6.5.1 Company Overview 52
• 6.6 Eli Lilly and Co 52
  • 6.6.1 Company Overview 52
• 6.7 F. Hoffmann-La Roche Ltd 53
  • 6.7.1 Company Overview 53
• 6.8 Ypsomed Holding AG 53
  • 6.8.1 Company Overview 53
• 6.9 Insulet Corp 53
  • 6.9.1 Company Overview 53

7 Diabetes Care Devices Market Pipeline Products 54

8 Financial Deals Landscape 55

• 8.1 Debt Offerings 55
  • 8.1.1 Bayer Raises USD1.1 Billion in Private Placement of 2.375% Bonds Due 2079 55
  • 8.1.2 Bayer Raises USD830.7 Million in Private Placement of 3.125% Bonds Due 2079 56
• 8.2 Equity Offerings 57
  • 8.2.1 DiaMonTech Postpones IPO of Shares 57
• 8.3 Partnerships 58
  • 8.3.1 DAK-Gesundheit and DiaMonTech Plan to Form Partnership 58
  • 8.3.2 Stevanato Group Enters into Licensing Agreement with Wilhelm Haselmeier 59
  • 8.3.3 LifeScan Enters into Distribution Agreement with Sanvita Medical 60
  • 8.3.4 Diabeloop and ViCentra Enter into Distribution Agreement 61

9 Recent Developments 62

• 9.1 Corporate Communications 62
  • 9.1.1 Feb 22, 2020: Bayer Cares Foundation donates over EUR 363,000 to support 94 social projects in 32 countries worldwide 62
  • 9.1.2 Sep 30, 2019: Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer 62
  • 9.1.3 Sep 10, 2019: Bayer reduces size of board of management from seven to five members 64
  • 9.1.4 Sep 03, 2019: Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee 64
  • 9.1.5 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 65
  • 9.1.6 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 66
  • 9.1.7 Apr 16, 2019: Ginkgo Bioworks appoints former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors 66
  • 9.1.8 Apr 12, 2019: Dr. Monika Lessl to lead both the Bayer Science and the Bayer Cares Foundations 67
• 9.2 Financial Announcements 68
  • 9.2.1 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth - outlook confirmed 68
  • 9.2.2 Jul 30, 2019: Bayer on track in operational business 70
  • 9.2.3 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 72
  • 9.2.4 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 73
• 9.3 Legal And Regulatory 74
  • 9.3.1 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents 74
• 9.4 Other Significant Developments 75
  • 9.4.1 Feb 27, 2020: Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures 75
  • 9.4.2 Jan 23, 2020: LB Pharmaceuticals starts dosing of schizophrenia drug 75
  • 9.4.3 Dec 10, 2019: Bayer to significantly step-up its sustainability efforts 76
  • 9.4.4 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 79
  • 9.4.5 Oct 21, 2019: CRISPR Therapeutics and Bayer announce an update on Casebia Therapeutics 80
  • 9.4.6 May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability 80
  • 9.4.7 Apr 25, 2019: Bayer: strong operational start to the year 82
• 9.5 Strategy And Business Planning 85
  • 9.5.1 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 85
  • 9.5.2 Aug 22, 2019: Ypsomed opens production plant in Schwerin 86

10 Appendix 87

• 10.1 Research Methodology 88
  • 10.1.1 Coverage 88
  • 10.1.2 Secondary Research 88
  • 10.1.3 Primary Research 89
  • 10.1.4 Market Modeling and Forecasting 89
  • 10.1.5 Company Share Analysis 91
  • 10.1.6 Distribution Share Analysis 91
  • 10.1.7 Benchmarking 92
• 10.2 GlobalData Consulting 92
• 10.3 Contact Us 93